Graph Therapeutics
AustriaEntry
2024
Hold
2yr
Status
Active
Who owns Graph Therapeutics?
Graph Therapeutics is an Austrian Biotech company, currently owned by SquareOne since 2025 and Merantix Capital.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
Merantix CapitalMerantix Capital AI Fund · 2026 · VC
2 ownership periods · full history below
Key facts
HQAustria
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Merantix CapitalActive
2024 · present(2yr) · Merantix Capital AI Fund · 2026 · VC
SquareOneActive
2025 · present(1yr) · SquareOne III · 2022 · VC
More from Merantix Capital AI Fund
Other portfolio companies in the same fund.
Germany
Switzerland
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Graph Therapeutics?
Graph Therapeutics is currently owned by SquareOne and Merantix Capital, through Merantix Capital AI Fund, since 2025.
When did SquareOne and 1 other acquire Graph Therapeutics?
SquareOne and 1 other acquired Graph Therapeutics in 2025.
Who has owned Graph Therapeutics over time?
Graph Therapeutics has been through 2 private-equity ownership periods: Merantix Capital · via Merantix Capital AI Fund · since 2024; SquareOne · via SquareOne III · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue